MedPath

Eye Drops Study for Myopia Control in Schoolchildren

Not Applicable
Conditions
Myopia, Progressive
Atropine Allergy
Interventions
Drug: eye drops
Registration Number
NCT03402100
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

The myopia prevalence in schoolchildren is high in Taiwan. The myopia progression is fast in children and often associated high myopia in later life. This prospective and randomized study to investigate the effect of myopia control in myopic children with ultra low concentrations of atropine eye drops and/or low concentrations of anti-allergic and inflammatory eye drops.

Detailed Description

Myopia onset earlier in children who would suffer a high degree of myopia in the future adulthood.and higher risk for retinal detachment, macular degeneration, and even blindness. In Taiwan, myopia macular degeneration is the first place of irreversible blind cause in the elderly. The evidence based medicine shows atropine is the most effective treatment for the progression of myopia so far, but the side effects including photophobia and near blurred vision often disturbing patients and resulting poor compliance and high drop-out rate.

Recently, the studies from Taiwan and Singapore showed that low concentrations of atropine (0.05% or 0.01%) can effectively inhibit the myopia progression, reduce the symptoms of photophobia, and to achieve favorable myopia control. Previous study found that myopia and allergic conjunctivitis and inflammation were related. The investigators designed a prospective and randomized study to investigate the effect of myopia control in myopic children with ultra low concentrations of atropine eye drops and/or low concentrations of anti-allergic and inflammatory eye drops. Due to environmental factors such as near work, after school class and outdoor activity are also great associated with myopia, the questionnaires also are collected in this study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Myopia diagnosed with the spherical equivalent refraction at least -0.5 diopter (D)
  • Must be able to use eye drops
Exclusion Criteria
  • astigmatism -1.50 D or greater
  • strabismus
  • amblyopia
  • cataract
  • glaucoma
  • any ocular diseases ocular surgery
  • history of systemic diseases (ex. asthma, heart disease...)
  • contact lenses user
  • orthokeratology user

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
0.01% atropineeye dropschildren who received 0.01% atropine for myopia
0.005% atropine plus 0.25% Ketorolaceye dropschildren who received 0.005% atropine plus 0.25% Ketorolac for myopia
0.25% Ketorolaceye dropschildren who received 0.25% Ketorolac for myopia
0.01% atropine plus 0.25% Ketorolaceye dropschildren who received 0.01% atropine plus 0.25% Ketorolac for myopia
0.005% atropineeye dropschildren who received 0.005% atropine for myopia
Primary Outcome Measures
NameTimeMethod
Axial length change (mm) measured by non-contact biometry1 year

Axial length change (mm) measured by non-contact biometry is another indicator of the myopia progression.

Cycloplegic spherical refraction change measured by auto-refractometer (Diopter)1 year

Cycloplegic spherical refraction change measured by auto-refractometer (Diopter) is the main indicator of the myopia progression.

Secondary Outcome Measures
NameTimeMethod
Pupil size (mm) by electronic rule1 year

measures Pupil size (mm) by electronic rule

Intraocular pressure (mmHg) by non-contact tonometer1 year

measures Intraocular pressure (mmHg) by non-contact tonometer

Anterior chamber depth (mm) measured by non-contact biometry1 year

measures Anterior chamber depth (mm) measured by non-contact biometry

Posterior chamber depth (mm) measured by non-contact biometry1 year

measures Posterior chamber depth (mm) measured by non-contact biometry

Accommodation (diopter) by accommodometer1 year

Accommodation change (diopter) by accommodometer is another indicator of the myopia progression.

Trial Locations

Locations (1)

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath